Granules India gets USFDA nod for generic Glycopyrrolate oral solution

Granules Pharmaceuticals Inc, a subsidiary of Granules India, has received approval from the USFDA for a generic Glycopyrrolate oral solution meant for pediatric patients with neurological conditions associated with drooling. The medication is bioequivalent to Cuvposa Oral Solution by Merz Pharmaceuticals and has a strength of 1mg/5mL.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/ZqfeGoK
via IFTTT